Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4QBF7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 119 | 123 | PF00656 | 0.757 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.331 |
CLV_NRD_NRD_1 | 251 | 253 | PF00675 | 0.514 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.420 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.413 |
CLV_PCSK_KEX2_1 | 251 | 253 | PF00082 | 0.514 |
CLV_PCSK_KEX2_1 | 260 | 262 | PF00082 | 0.420 |
CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.513 |
DEG_APCC_DBOX_1 | 259 | 267 | PF00400 | 0.490 |
DEG_APCC_DBOX_1 | 27 | 35 | PF00400 | 0.485 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.498 |
DEG_SPOP_SBC_1 | 110 | 114 | PF00917 | 0.565 |
DOC_CYCLIN_yCln2_LP_2 | 127 | 133 | PF00134 | 0.362 |
DOC_MAPK_gen_1 | 220 | 226 | PF00069 | 0.354 |
DOC_PP2B_LxvP_1 | 127 | 130 | PF13499 | 0.664 |
DOC_PP2B_LxvP_1 | 146 | 149 | PF13499 | 0.338 |
DOC_PP4_FxxP_1 | 5 | 8 | PF00568 | 0.474 |
DOC_USP7_MATH_1 | 110 | 114 | PF00917 | 0.725 |
DOC_USP7_MATH_1 | 196 | 200 | PF00917 | 0.403 |
DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.467 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.687 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.477 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.524 |
LIG_14-3-3_CanoR_1 | 164 | 174 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 28 | 32 | PF00244 | 0.712 |
LIG_14-3-3_CanoR_1 | 79 | 88 | PF00244 | 0.451 |
LIG_APCC_ABBA_1 | 88 | 93 | PF00400 | 0.546 |
LIG_eIF4E_1 | 174 | 180 | PF01652 | 0.350 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.494 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.366 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.528 |
LIG_FHA_2 | 254 | 260 | PF00498 | 0.376 |
LIG_LIR_Gen_1 | 159 | 170 | PF02991 | 0.518 |
LIG_LIR_Gen_1 | 241 | 250 | PF02991 | 0.354 |
LIG_LIR_Gen_1 | 282 | 290 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 128 | 134 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 150 | 154 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 159 | 165 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 241 | 247 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 282 | 288 | PF02991 | 0.530 |
LIG_MYND_1 | 273 | 277 | PF01753 | 0.581 |
LIG_SH2_CRK | 285 | 289 | PF00017 | 0.466 |
LIG_SH2_CRK | 97 | 101 | PF00017 | 0.342 |
LIG_SH2_NCK_1 | 97 | 101 | PF00017 | 0.342 |
LIG_SH2_STAP1 | 151 | 155 | PF00017 | 0.492 |
LIG_SH2_STAP1 | 158 | 162 | PF00017 | 0.485 |
LIG_SH2_STAP1 | 167 | 171 | PF00017 | 0.477 |
LIG_SH2_STAP1 | 244 | 248 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.340 |
LIG_SH2_STAT5 | 145 | 148 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.235 |
LIG_TRAF2_1 | 256 | 259 | PF00917 | 0.317 |
LIG_TRFH_1 | 145 | 149 | PF08558 | 0.309 |
LIG_TYR_ITIM | 242 | 247 | PF00017 | 0.349 |
LIG_UBA3_1 | 71 | 77 | PF00899 | 0.370 |
MOD_CDK_SPxxK_3 | 10 | 17 | PF00069 | 0.496 |
MOD_CDK_SPxxK_3 | 51 | 58 | PF00069 | 0.480 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.427 |
MOD_CK2_1 | 253 | 259 | PF00069 | 0.519 |
MOD_CK2_1 | 41 | 47 | PF00069 | 0.552 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.645 |
MOD_GlcNHglycan | 118 | 122 | PF01048 | 0.659 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.658 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.625 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.525 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.580 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.430 |
MOD_NEK2_2 | 189 | 194 | PF00069 | 0.381 |
MOD_PKA_1 | 79 | 85 | PF00069 | 0.395 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.690 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.423 |
MOD_Plk_1 | 156 | 162 | PF00069 | 0.482 |
MOD_Plk_1 | 196 | 202 | PF00069 | 0.401 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.286 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.688 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.479 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.512 |
TRG_ENDOCYTIC_2 | 145 | 148 | PF00928 | 0.310 |
TRG_ENDOCYTIC_2 | 167 | 170 | PF00928 | 0.555 |
TRG_ENDOCYTIC_2 | 244 | 247 | PF00928 | 0.357 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.558 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.338 |
TRG_ER_diArg_1 | 60 | 63 | PF00400 | 0.571 |
TRG_ER_diArg_1 | 78 | 80 | PF00400 | 0.340 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAY1 | Leptomonas seymouri | 54% | 100% |
A0A3Q8ICJ3 | Leishmania donovani | 91% | 100% |
A0A422NVZ5 | Trypanosoma rangeli | 37% | 100% |
A4HCN2 | Leishmania braziliensis | 77% | 100% |
A4I056 | Leishmania infantum | 92% | 100% |
E9AW19 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
V5AYT6 | Trypanosoma cruzi | 37% | 100% |
V5D0F5 | Trypanosoma cruzi | 37% | 100% |